Preferred Label : Azacitidine/Ivosidenib Regimen;
NCIt synonyms : Azacitidine/Tibsovo; Azacitidine-Ivosidenib; Azacitidine-Ivosidenib Regimen; Ivosidenib/Azacitidine; Azacitidine/Ivosidenib;
NCIt related terms : Azacitidine and Ivosidenib;
NCIt definition : A regimen consisting of azacitidine and ivosidenib that may be used in the treatment
of acute myeloid leukemia (AML).;
NCI Metathesaurus CUI : CL1799361;
Codes from synonyms : 49832;
Origin ID : C190721;
UMLS CUI : C5783883;
Est indiqué pour
- Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
https://ansm.sante.fr/actualites/avis-de-lansm-du-19-04-2023-sur-le-medicament-ivosidenib-250-mg-comprime-dans-le-cadre-dune-demande-daap
2023
false
false
false
France
French
drug information
ivosidenib
administration, oral
ivosidenib
Product containing precisely ivosidenib 250 milligram/1 each conventional release
oral tablet (clinical drug)
antineoplastic agents
leukemia, myeloid, acute
antineoplastic combined chemotherapy protocols
adult
azacitidine
Azacitidine/Ivosidenib Regimen
IDH1 NP_005887.2:p.R132X
---
https://www.has-sante.fr/jcms/p_3431997/fr/ivosidenib-servier-ivosidenib-leucemie-aigue-myeloide
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
ivosidenib
antineoplastic agents
antineoplastic combined chemotherapy protocols
Azacitidine/Ivosidenib Regimen
azacitidine
leukemia, myeloid, acute
mutation
enzyme inhibitors
IDH1 protein, human
administration, oral
evaluation of the transparency committee
leukemia, myeloid, acute
ivosidenib
---
